Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2017 | Pages:
100 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the EMEA Anti-malarial Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Anti-malarial Drugs for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Anti-malarial Drugs market competition by top manufacturers/players, with Anti-malarial Drugs sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck KGaA
F. Hoffmann-La Roche AG
Novartis AG
GlaxoSmithKline Plc
Ranbaxy Laboratories
Zydus Cadila
Alvizia Health Care
Bayer AG
Pfizer, Inc.
Ipca Laboratories Ltd
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Quinine
Chloroquine
Pyrimethamine
Amodiaquine
Proguanil
Mefloquine
Sulfonamide
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Falciparum Malaria
Vivax Malaria
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Anti-malarial Drugs Market Report 2017
1 Anti-malarial Drugs Overview
1.1 Product Overview and Scope of Anti-malarial Drugs
1.2 Classification of Anti-malarial Drugs
1.2.1 EMEA Anti-malarial Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Anti-malarial Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Quinine
1.2.4 Chloroquine
1.2.5 Pyrimethamine
1.2.6 Amodiaquine
1.2.7 Proguanil
1.2.8 Mefloquine
1.2.9 Sulfonamide
1.2.10 Other
1.3 EMEA Anti-malarial Drugs Market by Application/End Users
1.3.1 EMEA Anti-malarial Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Falciparum Malaria
1.3.3 Vivax Malaria
1.3.4 Others
1.4 EMEA Anti-malarial Drugs Market by Region
1.4.1 EMEA Anti-malarial Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Anti-malarial Drugs (2012-2022)
1.5.1 EMEA Anti-malarial Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Anti-malarial Drugs Revenue and Growth Rate (2012-2022)
2 EMEA Anti-malarial Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Anti-malarial Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Anti-malarial Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Anti-malarial Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Anti-malarial Drugs Sale Price by Players (2012-2017)
2.2 EMEA Anti-malarial Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Anti-malarial Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Anti-malarial Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Anti-malarial Drugs Sale Price by Type (2012-2017)
2.3 EMEA Anti-malarial Drugs (Volume) by Application
2.4 EMEA Anti-malarial Drugs (Volume and Value) by Region
2.4.1 EMEA Anti-malarial Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Anti-malarial Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Anti-malarial Drugs Sales Price by Region (2012-2017)
3 Europe Anti-malarial Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Anti-malarial Drugs Sales and Value (2012-2017)
3.1.1 Europe Anti-malarial Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Anti-malarial Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Anti-malarial Drugs Sales and Market Share by Type
3.3 Europe Anti-malarial Drugs Sales and Market Share by Application
3.4 Europe Anti-malarial Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Anti-malarial Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Anti-malarial Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Anti-malarial Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Anti-malarial Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Anti-malarial Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Anti-malarial Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Anti-malarial Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Anti-malarial Drugs Sales and Growth Rate (2012-2017)
4 Middle East Anti-malarial Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Anti-malarial Drugs Sales and Value (2012-2017)
4.1.1 Middle East Anti-malarial Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Anti-malarial Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Anti-malarial Drugs Sales and Market Share by Type
4.3 Middle East Anti-malarial Drugs Sales and Market Share by Application
4.4 Middle East Anti-malarial Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Anti-malarial Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Anti-malarial Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Anti-malarial Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Anti-malarial Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Anti-malarial Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Anti-malarial Drugs Sales and Growth Rate (2012-2017)
5 Africa Anti-malarial Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Anti-malarial Drugs Sales and Value (2012-2017)
5.1.1 Africa Anti-malarial Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Anti-malarial Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Anti-malarial Drugs Sales and Market Share by Type
5.3 Africa Anti-malarial Drugs Sales and Market Share by Application
5.4 Africa Anti-malarial Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Anti-malarial Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Anti-malarial Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Anti-malarial Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Anti-malarial Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Anti-malarial Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Anti-malarial Drugs Sales and Growth Rate (2012-2017)
6 EMEA Anti-malarial Drugs Manufacturers/Players Profiles and Sales Data
6.1 Merck KGaA
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-malarial Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck KGaA Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche AG
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Anti-malarial Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 F. Hoffmann-La Roche AG Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Novartis AG
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Anti-malarial Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Novartis AG Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline Plc
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Anti-malarial Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Plc Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Ranbaxy Laboratories
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Anti-malarial Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Ranbaxy Laboratories Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Zydus Cadila
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Anti-malarial Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Zydus Cadila Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Alvizia Health Care
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Anti-malarial Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Alvizia Health Care Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bayer AG
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Anti-malarial Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bayer AG Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Pfizer, Inc.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Anti-malarial Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Pfizer, Inc. Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Ipca Laboratories Ltd
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Anti-malarial Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Ipca Laboratories Ltd Anti-malarial Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
7 Anti-malarial Drugs Manufacturing Cost Analysis
7.1 Anti-malarial Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-malarial Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-malarial Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-malarial Drugs Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Anti-malarial Drugs Market Forecast (2017-2022)
11.1 EMEA Anti-malarial Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Anti-malarial Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Anti-malarial Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Anti-malarial Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Anti-malarial Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Anti-malarial Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Anti-malarial Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Anti-malarial Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Anti-malarial Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Anti-malarial Drugs Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Anti-malarial Drugs
Figure EMEA Anti-malarial Drugs Sales Volume (MT) by Type (2012-2022)
Figure EMEA Anti-malarial Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Quinine Product Picture
Figure Chloroquine Product Picture
Figure Pyrimethamine Product Picture
Figure Amodiaquine Product Picture
Figure Proguanil Product Picture
Figure Mefloquine Product Picture
Figure Sulfonamide Product Picture
Figure Other Product Picture
Figure EMEA Anti-malarial Drugs Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Anti-malarial Drugs by Application in 2016
Figure Falciparum Malaria Examples
Table Key Downstream Customer in Falciparum Malaria
Figure Vivax Malaria Examples
Table Key Downstream Customer in Vivax Malaria
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Anti-malarial Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Anti-malarial Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Anti-malarial Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Anti-malarial Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anti-malarial Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Anti-malarial Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Anti-malarial Drugs Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Anti-malarial Drugs Sales Share by Players (2012-2017)
Figure 2016 Anti-malarial Drugs Sales Share by Players
Figure 2017 Anti-malarial Drugs Sales Share by Players
Figure EMEA Anti-malarial Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Anti-malarial Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Anti-malarial Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Anti-malarial Drugs Revenue Share by Players
Table 2017 EMEA Anti-malarial Drugs Revenue Share by Players
Table EMEA Anti-malarial Drugs Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Anti-malarial Drugs Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Anti-malarial Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-malarial Drugs by Type (2012-2017)
Figure EMEA Anti-malarial Drugs Sales Market Share by Type (2012-2017)
Table EMEA Anti-malarial Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Anti-malarial Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-malarial Drugs by Type in 2016
Table EMEA Anti-malarial Drugs Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Anti-malarial Drugs Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Anti-malarial Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Anti-malarial Drugs by Application (2012-2017)
Figure EMEA Anti-malarial Drugs Sales Market Share by Application in 2016
Table EMEA Anti-malarial Drugs Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Anti-malarial Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-malarial Drugs by Region (2012-2017)
Figure EMEA Anti-malarial Drugs Sales Market Share in 2016
Table EMEA Anti-malarial Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Anti-malarial Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Anti-malarial Drugs by Region (2012-2017)
Figure EMEA Anti-malarial Drugs Revenue Market Share Regions in 2016
Table EMEA Anti-malarial Drugs Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Europe Anti-malarial Drugs Revenue and Growth Rate (2012-2017)
Table Europe Anti-malarial Drugs Sales (MT) by Type (2012-2017)
Table Europe Anti-malarial Drugs Market Share by Type (2012-2017)
Figure Europe Anti-malarial Drugs Market Share by Type in 2016
Table Europe Anti-malarial Drugs Sales (MT) by Application (2012-2017)
Table Europe Anti-malarial Drugs Market Share by Application (2012-2017)
Figure Europe Anti-malarial Drugs Market Share by Application in 2016
Table Europe Anti-malarial Drugs Sales (MT) by Countries (2012-2017)
Table Europe Anti-malarial Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Anti-malarial Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Anti-malarial Drugs Sales Market Share by Countries in 2016
Table Europe Anti-malarial Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Anti-malarial Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-malarial Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-malarial Drugs Revenue Market Share by Countries in 2016
Figure Germany Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure France Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UK Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Russia Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Italy Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Anti-malarial Drugs Sales (MT) by Type (2012-2017)
Table Middle East Anti-malarial Drugs Market Share by Type (2012-2017)
Figure Middle East Anti-malarial Drugs Market Share by Type (2012-2017)
Table Middle East Anti-malarial Drugs Sales (MT) by Applications (2012-2017)
Table Middle East Anti-malarial Drugs Market Share by Applications (2012-2017)
Figure Middle East Anti-malarial Drugs Sales Market Share by Application in 2016
Table Middle East Anti-malarial Drugs Sales Volume (MT) by Countries (2012-2017)
Table Middle East Anti-malarial Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Anti-malarial Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Anti-malarial Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Anti-malarial Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-malarial Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-malarial Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Israel Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UAE Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Iran Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Anti-malarial Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Anti-malarial Drugs Sales (MT) by Type (2012-2017)
Table Africa Anti-malarial Drugs Sales Market Share by Type (2012-2017)
Figure Africa Anti-malarial Drugs Sales Market Share by Type (2012-2017)
Figure Africa Anti-malarial Drugs Sales Market Share by Type in 2016
Table Africa Anti-malarial Drugs Sales (MT) by Application (2012-2017)
Table Africa Anti-malarial Drugs Sales Market Share by Application (2012-2017)
Figure Africa Anti-malarial Drugs Sales Market Share by Application (2012-2017)
Table Africa Anti-malarial Drugs Sales Volume (MT) by Countries (2012-2017)
Table Africa Anti-malarial Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Anti-malarial Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Anti-malarial Drugs Sales Market Share by Countries in 2016
Table Africa Anti-malarial Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Anti-malarial Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-malarial Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-malarial Drugs Revenue Market Share by Countries in 2016
Figure South Africa Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Table Merck KGaA Anti-malarial Drugs Basic Information List
Table Merck KGaA Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck KGaA Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Merck KGaA Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck KGaA Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche AG Anti-malarial Drugs Basic Information List
Table F. Hoffmann-La Roche AG Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche AG Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Anti-malarial Drugs Basic Information List
Table Novartis AG Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Novartis AG Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Plc Anti-malarial Drugs Basic Information List
Table GlaxoSmithKline Plc Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table Ranbaxy Laboratories Anti-malarial Drugs Basic Information List
Table Ranbaxy Laboratories Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ranbaxy Laboratories Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Ranbaxy Laboratories Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure Ranbaxy Laboratories Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table Zydus Cadila Anti-malarial Drugs Basic Information List
Table Zydus Cadila Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Zydus Cadila Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Zydus Cadila Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure Zydus Cadila Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table Alvizia Health Care Anti-malarial Drugs Basic Information List
Table Alvizia Health Care Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Alvizia Health Care Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Alvizia Health Care Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure Alvizia Health Care Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Anti-malarial Drugs Basic Information List
Table Bayer AG Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer AG Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Bayer AG Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer, Inc. Anti-malarial Drugs Basic Information List
Table Pfizer, Inc. Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer, Inc. Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer, Inc. Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table Ipca Laboratories Ltd Anti-malarial Drugs Basic Information List
Table Ipca Laboratories Ltd Anti-malarial Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ipca Laboratories Ltd Anti-malarial Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Ipca Laboratories Ltd Anti-malarial Drugs Sales Market Share in EMEA (2012-2017)
Figure Ipca Laboratories Ltd Anti-malarial Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-malarial Drugs
Figure Manufacturing Process Analysis of Anti-malarial Drugs
Figure Anti-malarial Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-malarial Drugs Major Manufacturers in 2016
Table Major Buyers of Anti-malarial Drugs
Table Distributors/Traders List
Figure EMEA Anti-malarial Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-malarial Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-malarial Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Anti-malarial Drugs Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Anti-malarial Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Anti-malarial Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Anti-malarial Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Anti-malarial Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Anti-malarial Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Anti-malarial Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Anti-malarial Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-malarial Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Anti-malarial Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-malarial Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Anti-malarial Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Anti-malarial Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Anti-malarial Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Anti-malarial Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Anti-malarial Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Anti-malarial Drugs Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Anti-malarial Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Anti-malarial Drugs Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Anti-malarial Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
